Medicinal classification of Juri-Tap upheld where added ingredients did not alter quinine sulphate's therapeutic character.

Classification of the product "Juri-Tap" turned on whether the added ingredients, magnesium sulphate and ferrous sulphate, displaced the therapeutic or prophylactic character of quinine sulphate, the principal active ingredient. The Tribunal held that the ancillary ingredients did not alter that medicinal character, and the product remained classifiable under sub-heading 3003.11 rather than 3003.90. The view was reinforced by the assessee's earlier case on the same product, where the same classification had already been accepted and the Revenue's challenge rejected. The appeal succeeded and consequential relief followed on the classification dispute.

---

---

Issues: Whether the product "Juri-Tap" was correctly classifiable under sub-heading 3003.11 or was liable to be classified under sub-heading 3003.90.

Analysis: The product's classification depended on whether the added ingredients, namely magnesium sulphate and ferrous sulphate, interfered with the therapeutic or prophylactic activity of quinine sulphate, the principal active ingredient. The Tribunal noted that the same product had already been held classifiable under sub-heading 3003.11 in the appellant's own earlier case, and the Revenue's appeal against that view had been rejected.

Conclusion: The product was held to be classifiable under sub-heading 3003.11 and not under sub-heading 3003.90, in favour of the assessee.

Final Conclusion: The appeal succeeded and the assessee obtained consequential relief on the classification dispute.

Ratio Decidendi: Where the principal medicinal ingredient retains its therapeutic or prophylactic function and the ancillary ingredients do not displace that character, classification under the medicinal sub-heading is maintained.

---